Bavarian Nordic ASBVNKF 82 PB Ratio is 1.09 as of Jul. 03, 2026, which is 51% below its 10-year median of 2.22. GuruFocus rates BVNKF with a GF Score™ of 82/100 and a GF Value™ of $25.00 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 1,228 Biotechnology companies, Bavarian Nordic AS ranks better than 79.89% on this metric.
Bavarian Nordic AS stock PB Ratio (=1.11) is close to 1-year low of 1.05.
The historical rank and industry rank for Bavarian Nordic AS's PB Ratio or its related term are showing as below:
BVNKF'
s PB Ratio Range Over the Past 10 Years
Min: 0.96 Med: 2.22 Max: 6.4
Current: 1.11
During the past 13 years, Bavarian Nordic AS's highest PB Ratio was 6.40. The lowest was 0.96. And the median was 2.22.
BVNKF's PB Ratio is ranked better than 79.89% of 1228
companies
in the Biotechnology industry
Industry Median: 2.97
vs BVNKF: 1.11
During the past 12 months, Bavarian Nordic AS's average Book Value Per Share Growth Rate was 10.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 17.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 14.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 15.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Bavarian Nordic AS was 67.80% per year. The lowest was -21.90% per year. And the median was 11.85% per year.
Back to Basics: PB Ratio
Bavarian Nordic AS (OTCPK:BVNKF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Bavarian Nordic AS PB Ratio Related Terms
Bavarian Nordic AS PB Ratio Historical Data
* Premium members only.
The historical data trend for Bavarian Nordic AS's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Bavarian Nordic AS's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bavarian Nordic AS PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bavarian Nordic AS's PB Ratio distribution charts can be found below:
* The bar in red indicates where Bavarian Nordic AS's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Bavarian Nordic AS (BVNKF) has a PB Ratio of 1.09 as of Jul. 03, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Bavarian Nordic AS and its competitors. This is 51% below median its historical median of 2.22. Over the past decade, Bavarian Nordic AS's PB Ratio has ranged from 0.96 to 6.40. According to the industry distribution chart, Bavarian Nordic AS ranks #247 out of 1228 companies in the Biotechnology industry, placing it in the top 20.1%.
Is Bavarian Nordic AS's PB Ratio too high?
Bavarian Nordic AS's current PB Ratio of 1.09 is 51% below median its 10-year median of 2.22. Over the past 10 years, this metric has ranged from a low of 0.96 to a high of 6.40. The Biotechnology industry median PB Ratio is 2.97. Bavarian Nordic AS's value of 1.09 is 63.3% below this industry median. Based on the distribution chart, Bavarian Nordic AS ranks #247 out of 1228 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Bavarian Nordic AS has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bavarian Nordic AS's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bavarian Nordic AS ranks #247 out of 1228 companies for PB Ratio. This places Bavarian Nordic AS in the top 20% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.97. Bavarian Nordic AS's value of 1.09 is 63.3% below this benchmark. Historically, Bavarian Nordic AS's own PB Ratio has ranged from 0.96 to 6.40 over the past decade. While the company's 10-year median is 2.22 vs. the industry median of 2.97, Bavarian Nordic AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.97, based on 1,228 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bavarian Nordic AS's current PB Ratio of 1.09 is 63.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Bavarian Nordic AS and its competitors. For the Biotechnology industry, the median PB Ratio is 2.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bavarian Nordic AS's current PB Ratio is 1.09, which is 51% below median its own 10-year median of 2.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bavarian Nordic AS stock overvalued right now?
Based on GuruFocus' analysis, Bavarian Nordic AS (BVNKF) is currently considered Modestly Overvalued. The stock's GF Value™ is $25.00, compared to a current price of $27.69 — trading 10.8% above its estimated fair value. The current PB Ratio is 1.09, which is 51% below median its 10-year median of 2.22 and 63.3% below the Biotechnology industry median of 2.97. Bavarian Nordic AS's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Bavarian Nordic AS (BVNKF), the current PB Ratio is 1.09 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bavarian Nordic AS (BVNKF) Overvalued in 2026?
Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued.
The current stock price of $27.69 is trading 10.8% above its estimated GF Value™ of $25.00.
GuruFocus considers Bavarian Nordic AS to be Modestly Overvalued.
Key valuation signals for BVNKF:
PB Ratio: 1.09 (51% below median its 10-year median of 2.22)
GF Value™: $25.00 vs. price of $27.69 (10.8% above fair value)
Industry Position: 63.3% below the Biotechnology median (#247 of 1228)
No single metric tells the full story. See the BVNKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
82GF Score
Get the complete analysis for BVNKF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BVNKF has been successfully added to your 
